IL4 and breast carcinoma: IL-4 has been shown to have a modest but direct inhibitory effect on the growth of tumor cells of hematopoietic and nonhematopoietic origin in vitro and in vivo, including those derived from human melanoma, non-Hodgkin’s malignant B-lymphoma, and colon, renal, gastric, and breast carcinoma [43–47].